After signing up, you'll start to receive regular news updates from us.
Regulators OK Agilent buy of Stratagene
Complete the form below to unlock access to ALL audio articles.
Federal antitrust regulators said Thursday (10 may) they approved Agilent Technologies Inc.'s $246.2 million purchase of Stratagene Corp., which makes life science research and testing products.
According to a Federal Trade Commission notice, the government has completed its investigation of the deal and ended a waiting period on the cash transaction.
Santa Clara, Calif.-based Agilent, which makes measurement and testing devices for the electronics, communications, and life sciences industries, said April 6 that it would buy the La Jolla, Calif.-based Stratagene.
Shares of Agilent dropped 66 cents to $36.78 in morning trading Thursday, while shares of Stratagene rose 8 cents to $10.85.
